Denise Braendgaard: How Partnership is Turning Ambition Into Action
Denise Braendgaard, General Manager at Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, shared Novo Nordisk Haemophilia and Haemoglobinopathies Foundation‘s post on LinkedIn, adding:
“2025 was a year of transformation
At the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, we expanded our vision and scope, doubling down on our commitment to sustainable access to care for people living with haemophilia and haemoglobinopathies in low- and middle-income countries.
This progress was made possible by our partners: Their leadership, expertise, and dedication continue to drive sustainable, locally anchored impact.
Our Year in Review 2025 captures the milestones, the momentum, and the collective impact achieved together.
I invite you to take a moment to read it and see how partnership is turning ambition into action.”
Novo Nordisk Haemophilia and Haemoglobinopathies Foundation shared a post on LinkedIn:
“The NNHF Year in Review 2025 is here!
This year we focused on ‘Fostering connections and unveiling new horizons’, and the results speak for themselves.
Thanks to our partners, volunteers and funders, we reached new communities, launched meaningful initiatives, and expanded our impact.
Swipe through for some of the highlights, then read the Full Report for stories and outcomes that inspire.”
Other posts featuring Denise Braendgaard on Hemostasis Today.”
-
Mar 9, 2026, 16:28Augustina Isioma Ikusemoro: Is Blood Really Affordable?
-
Mar 9, 2026, 16:26Todd Maderis: Great Conversation on Effective Treatment of Chronic Infections
-
Mar 9, 2026, 16:10Veronica Sanchez: Recognizing the Risks of Preeclampsia During Pregnancy and Newly Postpartum
-
Mar 9, 2026, 16:06Abdul Mannan: Explaining the Molecular Mechanism Behind VITT
-
Mar 9, 2026, 16:03Wathsala Manindrani: Managing Severe Hypertriglyceridemia in Resource-Limited Settings
-
Mar 9, 2026, 15:55Honoring the Volunteers, Advocates, and Families Driving Awareness and Research of Glanzmann Thrombasthenia – GRF
-
Mar 9, 2026, 15:50Filippo Mazzi: IVIG as an Alternative Therapy for Acute Chest Syndrome in Patients with Sickle Cell Disease
-
Mar 9, 2026, 15:45llenia Calcaterra: Women’s Empowerment Through Autonomy, Education, and Financial Independence
-
Mar 9, 2026, 15:36Alyaa Al-Mughairy: Rethinking Emicizumab Low-Dose Regimens to Ensure Safe and Sustainable Patient Access